<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
62037-667-01
</NDCCode>
<PackageDescription>
100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (62037-667-01)
</PackageDescription>
<NDC11Code>
62037-0667-01
</NDC11Code>
<ProductNDC>
62037-667
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Divalproex Sodium
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Divalproex Sodium
</NonProprietaryName>
<DosageFormName>
TABLET, DELAYED RELEASE
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20110225
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA079080
</ApplicationNumber>
<LabelerName>
Watson Pharma, Inc.
</LabelerName>
<SubstanceName>
DIVALPROEX SODIUM
</SubstanceName>
<StrengthNumber>
500
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes>
Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2017-02-17
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>